Who has invested in Cerevel Therapeutics?

Perceptive Advisors are named among the investors backing Cerevel Therapeutics.

Cerevel Therapeutics Funding: $445M Raised, IPO (2020)

Cerevel Therapeutics funding overview

Cerevel Therapeutics has raised $445M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in July 2020. The round record for Cerevel Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Perceptive Advisors.

Cerevel Therapeutics at a glance

Total raised: $445M
Latest round: IPO
Latest round date: July 2020
Notable investors: Perceptive Advisors

Frequently asked about Cerevel Therapeutics funding

How much has Cerevel Therapeutics raised?: Cerevel Therapeutics has raised $445M in total disclosed funding across the rounds on record.
Who has invested in Cerevel Therapeutics?: Perceptive Advisors are named among the investors backing Cerevel Therapeutics.
What was the latest Cerevel Therapeutics funding round?: The most recent disclosed round is an IPO, announced in July 2020.
Where is Cerevel Therapeutics based?: No headquarters location is disclosed for Cerevel Therapeutics.
When did Cerevel Therapeutics last raise?: The last disclosed Cerevel Therapeutics round closed in July 2020 at IPO.

Every Cerevel Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.

Cerevel Therapeutics Funding: $445M Raised, IPO (2020)

Cerevel Therapeutics funding overview

Cerevel Therapeutics at a glance

Frequently asked about Cerevel Therapeutics funding

Companies related to Cerevel Therapeutics (18)

Browse related funding lists (4)